*March 2021*
In this podcast, Benjamin P. Levy, MD, an associate professor of oncology and clinical director of Medical Oncology at Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, discusses exciting research with targeted therapies for patients with lung cancer who harbor molecular abberations.
Dr. Levy discusses recent advances in NTRK-, KRAS-, and HER2-altered lung cancer.
Listen to the podcast here.
